Blood–Brain Barrier Technology and Gene Therapy
Gene therapy offers promising solutions for neurological disorders, but delivering genetic material to the brain is difficult due to the blood–brain barrier. BBB technology supports safe and efficient gene delivery strategies.
Viral and non-viral vectors are engineered to cross the BBB and deliver therapeutic genes to specific brain cells. Targeted delivery reduces off-target effects and improves treatment precision.
Nanoparticle-based gene carriers protect genetic material from degradation and facilitate controlled release. These systems enhance stability and effectiveness.
Blood–brain barrier technology also enables repeated or long-term gene therapy by minimizing immune responses. This is essential for treating chronic neurological conditions.
The combination of gene therapy and BBB technology opens new avenues for treating inherited and degenerative brain disorders.